Immunotherapy drug for triple negative breast cancer ‘rejected’ for NHS use
The first targeted immunotherapy treatment for people with triple negative breast cancer has been provisionally rejected for use on the NHS. The National Institute for Health and Care Excellence (Nice)
Read More